As of 2025-12-19, the Relative Valuation of Surmodics Inc (SRDX) is (43.05) USD. This relative valuation is based on P/E multiples. With the latest stock price at 42.98 USD, the upside of Surmodics Inc based on Relative Valuation is -200.2%.
The range of the Relative Valuation is (43.02) - (44.62) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 34.9x - 39.9x | 36.2x |
| Forward P/E multiples | 30.8x - 36.2x | 33.6x |
| Fair Price | (43.02) - (44.62) | (43.05) |
| Upside | -200.1% - -203.8% | -200.2% |
| Date | P/E |
| 2025-11-18 | -34.87 |
| 2025-11-17 | -34.75 |
| 2025-11-14 | -33.76 |
| 2025-11-13 | -33.59 |
| 2025-11-12 | -33.55 |
| 2025-11-11 | -33.21 |
| 2025-11-10 | -22.18 |
| 2025-11-07 | -21.73 |
| 2025-11-06 | -21.43 |
| 2025-11-05 | -22.35 |
| 2025-11-04 | -22.31 |
| 2025-11-03 | -22.97 |
| 2025-10-31 | -22.26 |
| 2025-10-30 | -22.04 |
| 2025-10-29 | -21.85 |
| 2025-10-28 | -22.20 |
| 2025-10-27 | -22.28 |
| 2025-10-24 | -22.11 |
| 2025-10-23 | -22.31 |
| 2025-10-22 | -22.94 |
| 2025-10-21 | -22.80 |
| 2025-10-20 | -22.82 |
| 2025-10-17 | -22.71 |
| 2025-10-16 | -22.72 |
| 2025-10-15 | -22.49 |
| 2025-10-14 | -22.38 |
| 2025-10-13 | -22.65 |
| 2025-10-10 | -23.23 |
| 2025-10-09 | -23.37 |
| 2025-10-08 | -23.29 |
| 2025-10-07 | -23.38 |
| 2025-10-06 | -23.28 |
| 2025-10-03 | -23.62 |
| 2025-10-02 | -24.26 |
| 2025-10-01 | -24.26 |
| 2025-09-30 | -24.25 |
| 2025-09-29 | -24.26 |
| 2025-09-26 | -24.29 |
| 2025-09-25 | -25.00 |
| 2025-09-24 | -24.71 |
| 2025-09-23 | -25.23 |
| 2025-09-22 | -26.10 |